Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete Coding Genome Sequence of an Influenza A/H3N8 Equine Virus Isolated in Kazakhstan in 2007.
Burashev Y, Orynbayev M, Zakarya K, Abduraimov Y, Kassenov M, Strochkov V, Kozhabergenov N, Usserbayev B, Melisbek A, Shirinbekov M, Sypatay N, Sultankulova K. Burashev Y, et al. Among authors: kassenov m. Microbiol Resour Announc. 2022 Oct 20;11(10):e0114721. doi: 10.1128/mra.01147-21. Epub 2022 Sep 12. Microbiol Resour Announc. 2022. PMID: 36094178 Free PMC article.
Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.
Sarsenbayeva G, Issagulov T, Kassenov M, Abitay R, Orynbayev M, Stukova M, Pisareva M, Davlyatshin T, Lespek K, Khairullin B. Sarsenbayeva G, et al. Among authors: kassenov m. Hum Vaccin Immunother. 2020 Aug 2;16(8):1791-1797. doi: 10.1080/21645515.2019.1705691. Epub 2020 Feb 12. Hum Vaccin Immunother. 2020. PMID: 32048890 Free PMC article. Clinical Trial.
Near-Complete Genome Sequence of an H5N1 Avian Influenza Virus Strain Isolated from a Swan in Southwest Kazakhstan in 2006.
Burashev Y, Strochkov V, Sultankulova K, Orynbayev M, Kassenov M, Kozhabergenov N, Shorayeva K, Sadikaliyeva S, Issabek A, Almezhanova M, Nakhanov A, Savitskaya I, Zakarya K. Burashev Y, et al. Among authors: kassenov m. Microbiol Resour Announc. 2020 Mar 26;9(13):e00016-20. doi: 10.1128/MRA.00016-20. Microbiol Resour Announc. 2020. PMID: 32217669 Free PMC article.
Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan.
Zakarya K, Kutumbetov L, Orynbayev M, Abduraimov Y, Sultankulova K, Kassenov M, Sarsenbayeva G, Kulmagambetov I, Davlyatshin T, Sergeeva M, Stukova M, Khairullin B. Zakarya K, et al. Among authors: kassenov m. EClinicalMedicine. 2021 Sep;39:101078. doi: 10.1016/j.eclinm.2021.101078. Epub 2021 Aug 14. EClinicalMedicine. 2021. PMID: 34414368 Free PMC article.
Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine.
Zhugunissov K, Kilibayev S, Mambetaliyev M, Zakarya K, Kassenov M, Abduraimov Y, Bulatov Y, Azanbekova M, Absatova Z, Abeuov K, Nurgaziev R, Renukaradhya GJ, Tabynov K. Zhugunissov K, et al. Among authors: kassenov m. Front Vet Sci. 2021 Aug 16;8:721023. doi: 10.3389/fvets.2021.721023. eCollection 2021. Front Vet Sci. 2021. PMID: 34485443 Free PMC article.
Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters.
Zhugunissov K, Zakarya K, Khairullin B, Orynbayev M, Abduraimov Y, Kassenov M, Sultankulova K, Kerimbayev A, Nurabayev S, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Chervyakova O, Assanzhanova N, Burashev Y, Mambetaliyev M, Azanbekova M, Kopeyev S, Kozhabergenov N, Issabek A, Tuyskanova M, Kutumbetov L. Zhugunissov K, et al. Among authors: kassenov m. Front Microbiol. 2021 Sep 27;12:720437. doi: 10.3389/fmicb.2021.720437. eCollection 2021. Front Microbiol. 2021. PMID: 34646246 Free PMC article.
Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up.
Khairullin B, Zakarya K, Orynbayev M, Abduraimov Y, Kassenov M, Sarsenbayeva G, Sultankulova K, Chervyakova O, Myrzakhmetova B, Nakhanov A, Nurpeisova A, Zhugunissov K, Assanzhanova N, Nurabayev S, Kerimbayev A, Yershebulov Z, Burashev Y, Kulmagambetov I, Davlyatshin T, Sergeeva M, Buzitskaya Z, Stukova M, Kutumbetov L. Khairullin B, et al. Among authors: kassenov m. EClinicalMedicine. 2022 Jun 25;50:101526. doi: 10.1016/j.eclinm.2022.101526. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35770251 Free PMC article.
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19.
Nurpeisova A, Khairullin B, Abitaev R, Shorayeva K, Jekebekov K, Kalimolda E, Kerimbayev A, Akylbayeva K, Abay Z, Myrzakhmetova B, Nakhanov A, Absatova Z, Nurabayev S, Orynbayev M, Assanzhanova N, Abeuov K, Kutumbetov L, Kassenov M, Abduraimov Y, Zakarya K. Nurpeisova A, et al. Among authors: kassenov m. Hum Vaccin Immunother. 2022 Nov 30;18(5):2087412. doi: 10.1080/21645515.2022.2087412. Epub 2022 Aug 12. Hum Vaccin Immunother. 2022. PMID: 35960911 Free PMC article.
24 results